• Project
    • Overview
    • Research >
      • Work Packages
      • Individual Research Projects
    • Governance
  • Network
    • Beneficiaries
    • Partner Organisations
  • People
    • Supervisors >
      • Theodora Calogeropoulou
      • Rebecca Wade
      • Stefano Mangani
      • Christophe Rochais
      • Vasileios Roussis
      • Vasileia Ismini Alexaki
      • Achilleas Gravanis
      • Ka Wan Li
      • Dame Pamela Shaw
    • Early Stage Researchers >
      • ESR1: Daniele Narducci
      • ESR2: Alessia Latorrata
      • ESR3: Athanasios-Alexandros Tsengenes
      • ESR4: Christina Athanasiou
      • ESR5: Federica Carucci
      • ESR6: Mirjana Antonijević
      • ESR7: Paolo Giaccio
      • ESR8: Canelif Yilmaz
      • ESR9: Ana Aragón
      • ESR10: Débora Pita
      • ESR11: Thanasis Rogdakis
      • ESR12: Desponia Charou
      • ESR13: Evangelia Thanou
      • ESR14: Marco Destro
    • Scientific Advisory Board
  • Training
    • Approach
    • Objectives >
      • Secondments
    • Events >
      • 1st Network Week
      • 2nd Network Week
      • 3rd Network Week
  • Outreach
    • Events
    • Public Engagement
    • Results
    • Newsletter
  • News
  • Job Openings
    • Vacancies
    • Submit your application
  • Contact
EURONEUROTROPHIN
  • Project
    • Overview
    • Research >
      • Work Packages
      • Individual Research Projects
    • Governance
  • Network
    • Beneficiaries
    • Partner Organisations
  • People
    • Supervisors >
      • Theodora Calogeropoulou
      • Rebecca Wade
      • Stefano Mangani
      • Christophe Rochais
      • Vasileios Roussis
      • Vasileia Ismini Alexaki
      • Achilleas Gravanis
      • Ka Wan Li
      • Dame Pamela Shaw
    • Early Stage Researchers >
      • ESR1: Daniele Narducci
      • ESR2: Alessia Latorrata
      • ESR3: Athanasios-Alexandros Tsengenes
      • ESR4: Christina Athanasiou
      • ESR5: Federica Carucci
      • ESR6: Mirjana Antonijević
      • ESR7: Paolo Giaccio
      • ESR8: Canelif Yilmaz
      • ESR9: Ana Aragón
      • ESR10: Débora Pita
      • ESR11: Thanasis Rogdakis
      • ESR12: Desponia Charou
      • ESR13: Evangelia Thanou
      • ESR14: Marco Destro
    • Scientific Advisory Board
  • Training
    • Approach
    • Objectives >
      • Secondments
    • Events >
      • 1st Network Week
      • 2nd Network Week
      • 3rd Network Week
  • Outreach
    • Events
    • Public Engagement
    • Results
    • Newsletter
  • News
  • Job Openings
    • Vacancies
    • Submit your application
  • Contact

Workshop (CST-2) on Patenting and Commercialization in Biotech held by Ventac Partners

4/12/2019

0 Comments

 
All the ESRs had the great opportunity to attend a two-day workshop on Patenting and Commercialising Novel Biomedical Inventions held by Ventac Partners. Dr. Kostas Alevizopoulos and Dr. Neil Thomas brought the ESRs to the patent world, dealing with drawing up of a business plan, request for a patent and negotiation with investors for funding.
The topics of the course included all the steps required for the building of a start-up, starting from the development of a brilliant idea, exploration of the market, building of a financial model and a business plan. The ESRs enriched their knowledge on what a patent is, why it is important, what a patentable invention is, how patents are obtained and how long they last. Furthermore, they learnt what the Intellectual Properties Rights (IPRs) are, how to develop an IP strategy to accelerate the process and to safeguard IP assets, correct transfer of patent rights, mastering freedom to operate in the Biotech/MedTech industry, patent infringement, litigation and enforcement. In addition, they faced licensing models, term sheets, negotiation strategies and what an Elevator Pitch is.

This course was very informative for our ESRs; indeed, during the course, ESRs had the opportunity to work in groups on the development of a business plan regarding a new technology and including patenting options, freedom to operate position, bullet-point business plan, competitors, risks and hopes for the future. Additionally, ESRs dealt with the negotiation with a potential university for IP rights, performing in the end an elevator pitch in order to convince the investors to fund their project. During the work in groups, the students were tested for their creativity and determination to face all the problems that a patent can reserve.
Picture
Picture
0 Comments

EuroNeurotrophin School 2: In vivo models for neurodegenerative disorders: strengths and limitations

3/12/2019

0 Comments

 
The second training week of EuroNeurotrophin was held in the TU Dresden Faculty of Medicine, starting with School 2. The 4-day long school included theoretical lectures on in vivo models of neurodegenerative disorders, as well as hands-on experience in identification and analysis of these models. The school was organized by the contribution of the following network’s beneficiaries: TU Dresden Faculty of Medicine, Department of Clinical Pathobiochemistry (TUD), Foundation for Research and Technology Hellas, Institute of Molecular Biology and Biotechnology (IMBB-FoRTH), University of Sheffield, Sheffield Institute for Translational Neuroscience (SITraN) and Vrije Universiteit Amsterdam (VUA).
The first part of the School was taught by TUD, Dr. Vasileia Ismini Alexaki who gave a brief overview on the biology of the laboratory animals, animal welfare, regulations of animal experimentation and ethics of animal experimentation. Dr Alexaki then continued with the pathobiology of Multiple Sclerosis (MS) and mouse models of MS. The school continued by Canelif Yılmaz (ESR8) introducing assays and techniques used in animal experimentation, and she conducted hands on sessions on identification of various cell types of the CNS, identification of brain regions with the help of a brain atlas, and quantification of microgliosis and demyelination in Cuprizone mouse model of MS.

In the second part of the School, Prof. Ioannis Charalampopoulos and Dr. Kanelina Karali from IMBB-FoRTH gave lectures on Alzheimer’s disease (AD) pathology, AD pharmacology, animal models of AD, and ex vivo models of AD. Furthermore, Dr. Kanelina Karali conducted a practical session on behavioral tests used in AD mouse models, and quantification of Aß plaques. Finally, Prof. Ka-Wan Li from VUA gave a lecture on AD proteomics.

In the third and final part of the School, Dr. Richard J. Mead and Dr. Ramesh Tennore from SITraN gave lectures on Motor Neuron Disease (MND), while Dr. Richard Mead focused on mouse models of MND, readouts from these models, and design of in vivo studies. Dr. Ramesh Tennore focused on zebrafish biology, zebrafish models of MND, and high throughput screening conducted in zebrafish. 

The school provided the ESRs with in depth knowledge on pathology of the three major neurodegenerative diseases, MS, AD and MND, as well as currently available treatment options. Furthermore, commonly used animal models for the three diseases were introduced, models’ strengths and shortcomings were explained, and through the practical sessions, ESRs gained experience and insight on how they can utilize these models in their current and future research.
Picture
Picture
Picture
0 Comments

    Archives

    January 2021
    December 2020
    April 2020
    February 2020
    December 2019
    November 2019
    September 2019
    July 2019
    December 2018
    February 2018
    January 2018
    December 2017
    May 2017

    Categories

    All
    Events
    Research
    Training

    RSS Feed

Picture

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 765704
Disclaimer | Member Area
© accelopment Schweiz 2019. ALL RIGHTS RESERVED.
  • Project
    • Overview
    • Research >
      • Work Packages
      • Individual Research Projects
    • Governance
  • Network
    • Beneficiaries
    • Partner Organisations
  • People
    • Supervisors >
      • Theodora Calogeropoulou
      • Rebecca Wade
      • Stefano Mangani
      • Christophe Rochais
      • Vasileios Roussis
      • Vasileia Ismini Alexaki
      • Achilleas Gravanis
      • Ka Wan Li
      • Dame Pamela Shaw
    • Early Stage Researchers >
      • ESR1: Daniele Narducci
      • ESR2: Alessia Latorrata
      • ESR3: Athanasios-Alexandros Tsengenes
      • ESR4: Christina Athanasiou
      • ESR5: Federica Carucci
      • ESR6: Mirjana Antonijević
      • ESR7: Paolo Giaccio
      • ESR8: Canelif Yilmaz
      • ESR9: Ana Aragón
      • ESR10: Débora Pita
      • ESR11: Thanasis Rogdakis
      • ESR12: Desponia Charou
      • ESR13: Evangelia Thanou
      • ESR14: Marco Destro
    • Scientific Advisory Board
  • Training
    • Approach
    • Objectives >
      • Secondments
    • Events >
      • 1st Network Week
      • 2nd Network Week
      • 3rd Network Week
  • Outreach
    • Events
    • Public Engagement
    • Results
    • Newsletter
  • News
  • Job Openings
    • Vacancies
    • Submit your application
  • Contact